RESUMEN
No disponible
Asunto(s)
Humanos , Niño , Adolescente , Hipersensibilidad a los Alimentos/dietoterapia , Hipersensibilidad a los Alimentos/tratamiento farmacológico , Hipersensibilidad a los Alimentos/prevención & control , Instituciones Académicas , Anafilaxia , España , Acoso EscolarRESUMEN
Background and objectives Based on previous studies revealing acid-suppression medication as a risk factor for food allergy tolerance induction, we aimed to establish the importance of those findings in patients undergoing oral immunotherapy (OIT). Materials and methods, results We describe a case series of four patients who underwent milk OIT with a concomitant use of proton pump inhibitor (PPI) medication and who developed anaphylaxis after a known, previously tolerated dose of milk. Conclusions PPIs may act as a cofactor in patients undergoing OIT, triggering adverse reactions, irrespective of the PPI used or the dosage. It would be necessary to separate the administration of drug from food intake. Since OIT is a new form of treatment, long-term adverse events arising from PPI treatment and other possible triggers are still uncertain. Consequently, monitoring of patient must be prolonged over time. Additional investigations on the influence of different drugs in OIT maintenance phase are required (AU)
Asunto(s)
Humanos , Masculino , Femenino , Niño , Anafilaxia/etiología , Desensibilización Inmunológica/métodos , Esofagitis Eosinofílica/terapia , Hipersensibilidad a los Alimentos/terapia , Gastritis/terapia , Inhibidores de la Bomba de Protones/efectos adversosAsunto(s)
Hipersensibilidad a la Nuez/inmunología , Hipersensibilidad a la Nuez/prevención & control , Nueces/inmunología , Alérgenos/inmunología , Dermatitis Atópica/epidemiología , Dermatitis Atópica/inmunología , Manejo de la Enfermedad , Humanos , Inmunización , Hipersensibilidad a la Nuez/epidemiología , Nueces/efectos adversos , Nueces/clasificación , Hipersensibilidad al Cacahuete/epidemiología , Hipersensibilidad al Cacahuete/inmunología , Hipersensibilidad al Cacahuete/prevención & controlAsunto(s)
Proteínas en la Dieta/efectos adversos , Enterocolitis/epidemiología , Hipersensibilidad a los Alimentos/epidemiología , Preescolar , Proteínas en la Dieta/administración & dosificación , Enterocolitis/inducido químicamente , Enterocolitis/inmunología , Femenino , Hipersensibilidad a los Alimentos/inmunología , Humanos , Lactante , Recién Nacido , Estudios Longitudinales , Masculino , Prevalencia , Estudios ProspectivosRESUMEN
Vaccinations are one of the main public health tools for the control of vaccine-preventable diseases. If a child is identified as having had an allergic reaction to a vaccine, subsequent immunisations will probably be suspended - with the risks such a decision implies. The incidence of severe allergic reactions is very low, ranging between 0.5 and 1 cases/100,000 doses. Rather than the vaccine antigens as such, the causes of allergic reactions to vaccines are often residual protein components of the manufacturing process such as gelatine or egg, and less commonly yeasts or latex. Most vaccine reactions are mild and circumscribed to the injection site; although in some cases severe anaphylactic reactions can be observed. If an immediate-type allergic reaction is suspected at vaccination, or if a child with allergy to some of the vaccine components is scheduled for vaccination, a correct diagnosis of the possible allergic process must be made. The usual vaccine components must be known in order to determine whether vaccination can be safely performed
No disponible
Asunto(s)
Humanos , Masculino , Femenino , Niño , Hipersensibilidad/complicaciones , Hipersensibilidad/inmunología , Vacunas/efectos adversos , Vacunas/inmunología , Diagnóstico Diferencial , Inmunización/tendencias , Inmunización , Inmunoglobulina G/inmunología , Pruebas Cutáneas/instrumentación , Pruebas Cutáneas/métodos , Vacunas/clasificación , Hipersensibilidad/epidemiología , Hipersensibilidad/prevención & control , Vacunación/métodos , Vacunación , Encuestas y Cuestionarios , Anamnesis/métodosRESUMEN
Vaccinations are one of the main public health tools for the control of vaccine-preventable diseases. If a child is identified as having had an allergic reaction to a vaccine, subsequent immunisations will probably be suspended - with the risks such a decision implies. The incidence of severe allergic reactions is very low, ranging between 0.5 and 1 cases/100,000 doses. Rather than the vaccine antigens as such, the causes of allergic reactions to vaccines are often residual protein components of the manufacturing process such as gelatine or egg, and less commonly yeasts or latex. Most vaccine reactions are mild and circumscribed to the injection site; although in some cases severe anaphylactic reactions can be observed. If an immediate-type allergic reaction is suspected at vaccination, or if a child with allergy to some of the vaccine components is scheduled for vaccination, a correct diagnosis of the possible allergic process must be made. The usual vaccine components must be known in order to determine whether vaccination can be safely performed.